| Pharmaceutical active ingredients: |
| AspirinCaffeineDextropropoxyphene Hydrochloride |
| Available forms, composition and doses of Novo-Propoxyn Compound: |
| Capsules; Oral; Aspirin 375 mg; Caffeine 30 mg; Dextropropoxyphene Hydrochloride 65 mg |
| Novo-Propoxyn Compound medical category: |
| Human:Analgetics (Acetaminophen, Salicylates, Codeine)Opiate agonistsSalicylates |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AC54 - Dextropropoxyphene, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novopharm |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fortalidon | Aspirin; Caffeine; Codeine Phosphate; Propyphenazone | Novartis; Sandoz |
| Coristina D | Aspirin; Caffeine; Dexchlorpheniramine Maleate; Phenylephrine Hydrochloride | Schering-Plough |
| 692 Tablet | Aspirin; Caffeine; Dextropropoxyphene Hydrochloride | LIOH; Merck |
| Doloxene Co | Aspirin; Caffeine; Dextropropoxyphene Hydrochloride | Eli Lilly; Aspen Pharmacare |
| Novopropoxyn Compound | Aspirin; Caffeine; Dextropropoxyphene Hydrochloride | Novopharm |
| PC-Cap | Aspirin; Caffeine; Dextropropoxyphene Hydrochloride | Alra Laboratories |
| Darvon N Compound Pulvule 405 | Aspirin; Caffeine; Dextropropoxyphene Napsylate | Eli Lilly |
| Darvon-N Compound | Aspirin; Caffeine; Dextropropoxyphene Napsylate | Eli Lilly |
| Darvon-N Compuesto | Aspirin; Caffeine; Dextropropoxyphene Napsylate | Eli Lilly |
| Doloxene Compound | Aspirin; Caffeine; Dextropropoxyphene Napsylate | Eli Lilly |